EEG Biomarkers for OUD: Diagnostic, Prognostic, and Predictive Applications

Recruiting Observational Study
Opiod Use Disorder
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
22 – 85
Sex
Any
Study type
Observational
Participants needed
70 (estimated)
Sponsor
University of Illinois at Chicago · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
The US is suffering from a national opioid epidemic characterized by significant costs, overdoses, and deaths. Conventional Opioid Use Disorder (OUD) treatments (i.e., pharmacological and psychosocial interventions) are characterized by limited or diminishing efficacy, ceiling effects, and/or serious side effects. The availability of validated OUD biomarkers would be a key step in the development …
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * For OUD Subjects: 1. Providing informed consent to participate in the study. 2. 22 to 85 years old. Having a diagnosis of OUD • OUD of more than 6 months duration as defined by Diagnostic and Statistical Manual of Mental Disorders (DSM-5) \[71\] with a positive urine to…
Contacts

Aksarapak Hengyotmark, MD

312-257-4158

ahengy2@uic.edu

CONTACT